-
Symbol
-
EWTX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
6,541,210 shares
-
Security Ownership %
-
6.2%
Shares, Excluding Options vs Price
Paradigm BioCapital Advisors LP ownership in Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX)
17 Feb 2026 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,541,210 shares of Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX).
This represents 6.2% ownership of the company.
In their previous filing dated 03 Feb 2025, Paradigm Biocapital Advisors LP had reported owning 4,738,929 shares, indicating an increase of +38%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.